Cargando…

Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019

This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.

Detalles Bibliográficos
Autores principales:	Vokinger, Kerstin N., Hwang, Thomas J., Glaus, Camille E. G., Kesselheim, Aaron S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987900/ https://www.ncbi.nlm.nih.gov/pubmed/35385091 http://dx.doi.org/10.1001/jamanetworkopen.2022.6479

Ejemplares similares

Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021
por: Vokinger, Kerstin N., et al.
Publicado: (2022)

Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study
por: Vokinger, Kerstin N, et al.
Publicado: (2023)

Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
por: Hwang, Thomas J, et al.
Publicado: (2020)

Mitigating bias in machine learning for medicine
por: Vokinger, Kerstin N., et al.
Publicado: (2021)

Application of orphan drug designation to cancer treatments (2008–2017): a comprehensive and comparative analysis of the USA and EU
por: Vokinger, Kerstin Noëlle, et al.
Publicado: (2019)

Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021
por: Patel, Neeraj G., et al.
Publicado: (2023)

Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia
por: Hwang, Thomas J., et al.
Publicado: (2022)

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe
por: Carl, David L, et al.
Publicado: (2021)

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Assessment of the therapeutic value of new medicines marketed in Australia
por: Wonder, Michael J
Publicado: (2013)

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)

Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
por: Wallace, Beth I., et al.
Publicado: (2021)

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021)

Assessment of Menthol and Nonmenthol Cigarette Consumption in the US, 2000 to 2018
por: Delnevo, Cristine D., et al.
Publicado: (2020)

Practice Trends and Characteristics of US Hospitalists From 2012 to 2018
por: Ryskina, Kira L., et al.
Publicado: (2021)

The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study
por: Serra-Burriel, Miquel, et al.
Publicado: (2023)

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
por: Vreman, Rick A., et al.
Publicado: (2020)

Use of Real‐World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019
por: Eskola, Sini Marika, et al.
Publicado: (2021)

Evaluation of Housing Affordability Among US Resident Physicians
por: Brewster, Ryan C. L., et al.
Publicado: (2023)

Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland
por: Carl, David L., et al.
Publicado: (2022)

Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
por: Vitry, Agnes I
Publicado: (2013)

Phylogeographic Analysis of African Swine Fever Virus, Western Europe, 2018
por: Garigliany, Mutien, et al.
Publicado: (2019)

Orthopoxvirus Infections in Rodents, Nigeria, 2018–2019
por: Meseko, Clement, et al.
Publicado: (2023)

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)

Antimicrobial use in 20 U.S. beef feedyards: 2018–2019
por: Apley, Michael D., et al.
Publicado: (2023)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Letter to the editor: Is malaria re-emerging in southern Europe? Cryptic Plasmodium falciparum malaria in Malta, October 2018
por: Medialdea-Carrera, Raquel, et al.
Publicado: (2018)

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019
por: Troy, Aaron, et al.
Publicado: (2021)

Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018
por: Wallach, Joshua D., et al.
Publicado: (2021)

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
por: Rome, Benjamin N., et al.
Publicado: (2021)

Burkholderia pseudomallei in Soil, US Virgin Islands, 2019
por: Stone, Nathan E., et al.
Publicado: (2020)

Availability of New Medicines in the US and Germany From 2004 to 2018
por: Blankart, Katharina, et al.
Publicado: (2022)

Assessment of the therapeutic value of new medicines marketed in Australia
por: Vitry, Agnes I, et al.
Publicado: (2013)

Emergency department visits for vaccine-related severe allergic reactions among US adults: 2006-2018
por: Arroyo, Anna Chen, et al.
Publicado: (2022)

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023)

Linezolid- and Multidrug-Resistant Enterococci in Raw Commercial Dog Food, Europe, 2019–2020
por: Freitas, Ana R., et al.
Publicado: (2021)

Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021
por: Deshmukh, Anjali D., et al.
Publicado: (2023)

Anxiety in secondary school students in Al-Khobar, Saudi Arabia, 2018–2019
por: Uvais, Nalakath A.
Publicado: (2020)

Prevalence and Prescribers of Preoperative Opioid Prescriptions in the US, 2008-2019
por: Howard, Ryan, et al.
Publicado: (2022)

Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8rkrsl0k0hauq305ilsu8it09c